EA201100334A1 - Бициклические производные триазола для лечения опухолей - Google Patents
Бициклические производные триазола для лечения опухолейInfo
- Publication number
- EA201100334A1 EA201100334A1 EA201100334A EA201100334A EA201100334A1 EA 201100334 A1 EA201100334 A1 EA 201100334A1 EA 201100334 A EA201100334 A EA 201100334A EA 201100334 A EA201100334 A EA 201100334A EA 201100334 A1 EA201100334 A1 EA 201100334A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tumors
- treatment
- triazole
- bicyclic derivatives
- bicyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Abstract
Соединения формулы (I)в которой X, X, X, X, X, R, R, R, R', R, Rи Rимеют значения, указанные в п.1, являются ингибиторами тирозинкиназ, в особенности Met киназы, и могут применяться, среди прочего, для лечения опухолей.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008037790A DE102008037790A1 (de) | 2008-08-14 | 2008-08-14 | Bicyclische Triazolderivate |
PCT/EP2009/005172 WO2010017870A1 (de) | 2008-08-14 | 2009-07-16 | Bicyclische triazolderivate zur behandlung von tumoren |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201100334A1 true EA201100334A1 (ru) | 2011-08-30 |
Family
ID=41138729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201100334A EA201100334A1 (ru) | 2008-08-14 | 2009-07-16 | Бициклические производные триазола для лечения опухолей |
Country Status (17)
Country | Link |
---|---|
US (1) | US8435986B2 (ru) |
EP (1) | EP2310013B1 (ru) |
JP (1) | JP5475778B2 (ru) |
KR (1) | KR20110051243A (ru) |
CN (1) | CN102123710B (ru) |
AR (1) | AR073055A1 (ru) |
AU (1) | AU2009281491B2 (ru) |
BR (1) | BRPI0914555A2 (ru) |
CA (1) | CA2733941C (ru) |
DE (1) | DE102008037790A1 (ru) |
EA (1) | EA201100334A1 (ru) |
ES (1) | ES2648233T3 (ru) |
HK (1) | HK1159989A1 (ru) |
IL (1) | IL211193A0 (ru) |
MX (1) | MX2011001511A (ru) |
WO (1) | WO2010017870A1 (ru) |
ZA (1) | ZA201101899B (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2677696C1 (ru) * | 2013-12-09 | 2019-01-21 | Юсб Байофарма Спрл | Производные бензотриазола в качестве модуляторов активности tnf |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011515343A (ja) * | 2008-03-03 | 2011-05-19 | タイガー ファーマテック | チロシンキナーゼ阻害薬 |
HUE059696T2 (hu) | 2009-12-31 | 2022-12-28 | Hong Jia | Triazolopirazin-származékok, készítményeik és alkalmazási eljárásuk |
EP3450432A1 (en) * | 2010-05-17 | 2019-03-06 | Incozen Therapeutics Pvt. Ltd. | Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued - 3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases |
EP2619197B1 (en) * | 2010-09-23 | 2015-08-05 | Boehringer Ingelheim International GmbH | Oxadiazole inhibitors of leukotriene production |
DK3053923T3 (en) * | 2013-09-30 | 2018-07-23 | Korea Res Inst Chemical Tech | TRIAZOLOPYRAZINE DERIVATIVES AS TYROSIN KINASE INHIBITORS |
AU2014329560B2 (en) * | 2013-10-04 | 2017-03-02 | Novartis Ag | 3'end caps for RNAi agents for use in RNA interference |
EP3052107B1 (en) | 2013-10-04 | 2018-05-02 | Novartis AG | Organic compounds to treat hepatitis b virus |
CA2934679C (en) * | 2013-12-30 | 2023-02-28 | Genentech, Inc. | Serine/threonine kinase inhibitors |
KR20180114910A (ko) | 2016-02-05 | 2018-10-19 | 데날리 테라퓨틱스 인크. | 수용체-상호작용 단백질 키나제 1의 억제제 |
LT3552017T (lt) | 2016-12-09 | 2022-05-10 | Denali Therapeutics Inc. | Junginiai, naudotini kaip ripk1 inhibitoriai |
KR20180092096A (ko) | 2017-02-08 | 2018-08-17 | 에이비온 주식회사 | 트리아졸로 피라진 유도체의 신규한 다형체 및 이의 제조 방법 |
CN108570053A (zh) * | 2017-03-13 | 2018-09-25 | 中国科学院上海药物研究所 | 五元并六元杂环化合物、制备方法、中间体、组合和应用 |
US10710986B2 (en) | 2018-02-13 | 2020-07-14 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
JP7242702B2 (ja) | 2018-04-19 | 2023-03-20 | ギリアード サイエンシーズ, インコーポレイテッド | Pd-1/pd-l1阻害剤 |
UA126421C2 (uk) | 2018-07-13 | 2022-09-28 | Гіліад Сайєнсіз, Інк. | Інгібітори pd-1/pd-l1 |
CN112955435A (zh) | 2018-10-24 | 2021-06-11 | 吉利德科学公司 | Pd-1/pd-l1抑制剂 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
DE19604388A1 (de) | 1996-02-07 | 1997-08-14 | Merck Patent Gmbh | Arylalkyl-diazinone |
HUP9901155A3 (en) | 1996-02-13 | 2003-04-28 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
KR100489174B1 (ko) | 1996-03-05 | 2005-09-30 | 제네카-파마 소시에떼아노님 | 4-아닐리노퀴나졸린유도체 |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
JPH10259176A (ja) | 1997-03-17 | 1998-09-29 | Japan Tobacco Inc | 血管新生阻害作用を有する新規アミド誘導体及びその用途 |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
AUPQ462299A0 (en) | 1999-12-13 | 2000-01-13 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
US6242461B1 (en) | 2000-01-25 | 2001-06-05 | Pfizer Inc. | Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
CA2406979A1 (en) | 2000-05-31 | 2001-12-06 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
EE200300015A (et) | 2000-07-07 | 2004-10-15 | Angiogene Pharmaceuticals Limited | Kolhinooli derivaadid kui angiogeneesi inhibiitorid |
IL153484A0 (en) | 2000-07-07 | 2003-07-06 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors |
SK1862004A3 (en) | 2001-10-31 | 2004-08-03 | Type 4 phosphodiesterase inhibitors and uses thereof | |
DE10228103A1 (de) | 2002-06-24 | 2004-01-15 | Bayer Cropscience Ag | Fungizide Wirkstoffkombinationen |
JP2006514043A (ja) | 2002-12-20 | 2006-04-27 | ファルマシア・コーポレーション | マイトジェン活性化タンパク質キナーゼ−活性化タンパク質キナーゼ−2を阻害する化合物 |
US7563748B2 (en) | 2003-06-23 | 2009-07-21 | Cognis Ip Management Gmbh | Alcohol alkoxylate carriers for pesticide active ingredients |
CA2530589A1 (en) * | 2003-07-02 | 2005-01-20 | Sugen Inc. | Arylmethyl triazolo and imidazopyrazines as c-met inhibitors |
US7959919B2 (en) * | 2003-11-19 | 2011-06-14 | Novelmed Therapeutics, Inc. | Method of inhibiting factor B-mediated complement activation |
EP1769092A4 (en) | 2004-06-29 | 2008-08-06 | Europ Nickel Plc | IMPROVED LIXIVIATION OF BASE METALS |
US20070015771A1 (en) | 2004-07-29 | 2007-01-18 | Threshold Pharmaceuticals, Inc. | Lonidamine analogs |
US20070043057A1 (en) * | 2005-02-09 | 2007-02-22 | Threshold Pharmaceuticals, Inc. | Lonidamine analogs |
TW200612918A (en) * | 2004-07-29 | 2006-05-01 | Threshold Pharmaceuticals Inc | Lonidamine analogs |
AU2006264212B2 (en) | 2005-06-29 | 2010-10-28 | Compumedics Limited | Sensor assembly with conductive bridge |
EP1963329B1 (en) | 2005-11-30 | 2013-01-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-met and uses thereof |
DE102005057924A1 (de) | 2005-12-05 | 2007-06-06 | Merck Patent Gmbh | Pyridazinonderivate |
ME02736B (me) | 2005-12-21 | 2017-10-20 | Janssen Pharmaceutica Nv | Triazolopiridazini kao modulatori tirozin kinaze |
NL2000613C2 (nl) | 2006-05-11 | 2007-11-20 | Pfizer Prod Inc | Triazoolpyrazinederivaten. |
EP2032578A2 (en) | 2006-05-30 | 2009-03-11 | Pfizer Products Incorporated | Triazolopyridazine derivatives |
TW200801513A (en) | 2006-06-29 | 2008-01-01 | Fermiscan Australia Pty Ltd | Improved process |
PE20080403A1 (es) | 2006-07-14 | 2008-04-25 | Amgen Inc | Derivados heterociclicos fusionados y metodos de uso |
WO2008033455A2 (en) * | 2006-09-13 | 2008-03-20 | The Institutes For Pharmaceutical Discovery, Llc | Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
AU2007309237B2 (en) | 2006-10-23 | 2012-03-22 | Sgx Pharmaceuticals, Inc. | Triazolo-pyridazine protein kinase modulators |
DE102007026341A1 (de) * | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
RU2010121763A (ru) | 2007-10-31 | 2011-12-10 | Ниссан Кемикал Индастриз, Лтд. (Jp) | Производные пиридазинона и ингибиторы р2х7 рецептора |
DE102007061963A1 (de) | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
CN101538245B (zh) | 2008-03-18 | 2011-02-16 | 中国科学院上海药物研究所 | 一类哒嗪酮类化合物及其制备方法和制备药物的用途 |
DE102008019907A1 (de) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
EP2328586A2 (en) | 2008-05-20 | 2011-06-08 | Cephalon, Inc. | Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands |
DE102008028905A1 (de) | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
CN102105454A (zh) | 2008-07-25 | 2011-06-22 | 贝林格尔.英格海姆国际有限公司 | 合成1型11β-羟基类固醇脱氢酶的抑制剂 |
BRPI1013159A2 (pt) | 2009-03-30 | 2015-09-15 | Sumitomo Chemical Co | Uso de composto de piridazinona para controle de peste artrópode |
AR082590A1 (es) | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
-
2008
- 2008-08-14 DE DE102008037790A patent/DE102008037790A1/de not_active Withdrawn
-
2009
- 2009-07-16 WO PCT/EP2009/005172 patent/WO2010017870A1/de active Application Filing
- 2009-07-16 EP EP09777234.7A patent/EP2310013B1/de active Active
- 2009-07-16 AU AU2009281491A patent/AU2009281491B2/en active Active
- 2009-07-16 BR BRPI0914555A patent/BRPI0914555A2/pt not_active IP Right Cessation
- 2009-07-16 EA EA201100334A patent/EA201100334A1/ru unknown
- 2009-07-16 ES ES09777234.7T patent/ES2648233T3/es active Active
- 2009-07-16 CA CA2733941A patent/CA2733941C/en active Active
- 2009-07-16 MX MX2011001511A patent/MX2011001511A/es not_active Application Discontinuation
- 2009-07-16 US US13/059,016 patent/US8435986B2/en active Active
- 2009-07-16 CN CN2009801314380A patent/CN102123710B/zh active Active
- 2009-07-16 KR KR1020117005525A patent/KR20110051243A/ko not_active Application Discontinuation
- 2009-07-16 JP JP2011522392A patent/JP5475778B2/ja active Active
- 2009-08-14 AR ARP090103142A patent/AR073055A1/es unknown
-
2011
- 2011-02-10 IL IL211193A patent/IL211193A0/en active IP Right Grant
- 2011-03-11 ZA ZA2011/01899A patent/ZA201101899B/en unknown
-
2012
- 2012-01-12 HK HK12100381.3A patent/HK1159989A1/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2677696C1 (ru) * | 2013-12-09 | 2019-01-21 | Юсб Байофарма Спрл | Производные бензотриазола в качестве модуляторов активности tnf |
Also Published As
Publication number | Publication date |
---|---|
KR20110051243A (ko) | 2011-05-17 |
CA2733941A1 (en) | 2010-02-18 |
ES2648233T3 (es) | 2017-12-29 |
AR073055A1 (es) | 2010-10-13 |
CA2733941C (en) | 2016-10-04 |
AU2009281491B2 (en) | 2014-02-20 |
MX2011001511A (es) | 2011-03-15 |
JP2011530545A (ja) | 2011-12-22 |
CN102123710B (zh) | 2012-11-07 |
CN102123710A (zh) | 2011-07-13 |
US20110135600A1 (en) | 2011-06-09 |
DE102008037790A1 (de) | 2010-02-18 |
AU2009281491A1 (en) | 2010-02-18 |
US8435986B2 (en) | 2013-05-07 |
IL211193A0 (en) | 2011-04-28 |
HK1159989A1 (en) | 2012-08-10 |
WO2010017870A1 (de) | 2010-02-18 |
JP5475778B2 (ja) | 2014-04-16 |
BRPI0914555A2 (pt) | 2015-12-15 |
EP2310013B1 (de) | 2017-08-23 |
ZA201101899B (en) | 2011-11-30 |
EP2310013A1 (de) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201100334A1 (ru) | Бициклические производные триазола для лечения опухолей | |
EA201000093A1 (ru) | Производные пиридазинона | |
EA201100966A1 (ru) | Производные пиридазинона | |
EA200901601A1 (ru) | Производные пиридазинона | |
EA201001005A1 (ru) | Производные 2-бензилпиридазинона в качестве ингибиторов мет киназы | |
EA200901611A1 (ru) | Производные 2-оксо-3-бензил-бензоксазол-2-она и родственные соединения в качестве ингибиторов мет киназы для лечения опухолей | |
EA201001648A1 (ru) | Производные пиридазинона | |
EA200901603A1 (ru) | Арил-эфирные производные пиридазинона | |
MY153261A (en) | Pyridiazinone derivatives for tumour treatment | |
NO20065148L (no) | Monocykliske heterocykler som kinase inhibitorer | |
EA201070395A1 (ru) | Ингибиторы polo-подобных киназ | |
ATE554087T1 (de) | Neue kinaseinhibitoren | |
MX2008002104A (es) | Derivados de 1-acildihidropirazol. | |
EA201100580A1 (ru) | Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы | |
EA201000558A1 (ru) | Производные имидазола | |
EA201070480A1 (ru) | Ингибиторы с-fms киназы | |
EA200801430A1 (ru) | Производные триазола | |
EA201100035A1 (ru) | Производные тиазолилпиперидина | |
EA201000004A1 (ru) | Производные 6-(пирролопиридинил)пиримидин-2-иламина и их применение для лечения злокачественного новообразования и спида | |
EA201100031A1 (ru) | 3-(3-пиримидин-2-илбензил)-1,2,4-триазоло[4,3-b]пиридазин производные в качестве ингибиторов мет киназы | |
EA201000550A1 (ru) | Производные тиазола | |
EA201000618A1 (ru) | 5-цианотиенопиридины для лечения опухолей | |
EA201101041A1 (ru) | Производные пиридазинона | |
EA201001576A1 (ru) | Тиенопиримидины | |
EA201101042A1 (ru) | Производные бензотиазолона |